<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32350887</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0223</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>40</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Prenatal diagnosis</Title>
          <ISOAbbreviation>Prenat Diagn</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The utility of genome-wide cell-free DNA screening in the prenatal diagnosis of Pallister-Killian syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>1005</StartPage>
          <EndPage>1012</EndPage>
          <MedlinePgn>1005-1012</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/pd.5721</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To report genome-wide cell-free DNA (cfDNA) screening facilitating the diagnosis of Pallister-Killian syndrome (PKS).</AbstractText>
          <AbstractText Label="METHODS">This is a retrospective cohort analysis of positive genome-wide cfDNA screening results showing increased signal from chromosome 12 and the detection of PKS. The genome-wide cfDNA screening results and the subsequent investigations were reviewed.</AbstractText>
          <AbstractText Label="RESULTS">Three singleton pregnancies (3/29007) from 2016 to 2017 yielded positive results indicating large gains on the entire p-arm of chromosome 12. In two cases, multiple structural abnormalities were detected by prenatal ultrasound and the couples opted for termination of pregnancy. Chromosomal microarray performed on fetal skin tissues of the two abortuses detected mosaic tetrasomy 12p, consistent with PKS. In the third case, karyotype and chromosomal microarray performed on an amniotic fluid sample also showed mosaic tetrasomy 12p. In each of the three cases, genome-wide cfDNA screening revealed a large gain on chromosome 12p; subsequent prenatal or postnatal diagnostic testing confirmed the diagnosis of PKS.</AbstractText>
          <AbstractText Label="CONCLUSION">We report the ability of genome-wide cfDNA screening to provide early suspicion and facilitate the subsequent genetic diagnosis of PKS. As genome-wide cfDNA screening becomes increasingly available, incidental diagnosis of partial aneuploidies is expected to increase.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chau</LastName>
            <ForeName>Matthew Hoi Kin</ForeName>
            <Initials>MHK</Initials>
            <Identifier Source="ORCID">0000-0002-0945-1938</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lam</LastName>
            <ForeName>Doris Yuk Man</ForeName>
            <Initials>DYM</Initials>
            <AffiliationInfo>
              <Affiliation>NIPT Department, NGS Lab, Xcelom Limited, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Xiaofan</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0002-7303-1700</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kwok</LastName>
            <ForeName>Yvonne Ka Yin</ForeName>
            <Initials>YKY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Shatin, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ting</LastName>
            <ForeName>Yuen Ha</ForeName>
            <Initials>YH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chan</LastName>
            <ForeName>Wan Pang</ForeName>
            <Initials>WP</Initials>
            <AffiliationInfo>
              <Affiliation>Obstetrics &amp; Gynaecology Centre, Hong Kong Sanatorium &amp; Hospital, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Mengmeng</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheung</LastName>
            <ForeName>Sunny Wai Hung</ForeName>
            <Initials>SWH</Initials>
            <AffiliationInfo>
              <Affiliation>NIPT Department, NGS Lab, Xcelom Limited, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lau</LastName>
            <ForeName>Tze Kin</ForeName>
            <Initials>TK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Shatin, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fetal Medicine Centre, Paramount Medical Centre, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ville</LastName>
            <ForeName>Yves</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>EA 73-28, Faculté de Médecine de l'Université René Descartes, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leung</LastName>
            <ForeName>Tak Yeung</ForeName>
            <Initials>TY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Chinese University of Hong Kong-Baylor College of Medicine Joint Center for Medical Genetics, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choy</LastName>
            <ForeName>Kwong Wai</ForeName>
            <Initials>KW</Initials>
            <Identifier Source="ORCID">0000-0002-3616-6200</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Chinese University of Hong Kong-Baylor College of Medicine Joint Center for Medical Genetics, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D023362">Evaluation Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>05</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Prenat Diagn</MedlineTA>
        <NlmUniqueID>8106540</NlmUniqueID>
        <ISSNLinking>0197-3851</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000073888">Cell-Free Nucleic Acids</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C538105">Pallister Killian syndrome</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073888" MajorTopicYN="N">Cell-Free Nucleic Acids</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D025063" MajorTopicYN="N">Chromosome Disorders</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002881" MajorTopicYN="N">Chromosomes, Human, Pair 12</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055028" MajorTopicYN="Y">Comparative Genomic Hybridization</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D046228" MajorTopicYN="N">Microarray Analysis</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011296" MajorTopicYN="N">Prenatal Diagnosis</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32350887</ArticleId>
        <ArticleId IdType="doi">10.1002/pd.5721</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Taylor-Phillips S, Freeman K, Geppert J, et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open. 2016;6(1):e010002.</Citation>
        </Reference>
        <Reference>
          <Citation>Bianchi DW, Chiu RWK. Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med. 2018;379(5):464-473.</Citation>
        </Reference>
        <Reference>
          <Citation>Lo KK, Karampetsou E, Boustred C, et al. Limited clinical utility of non-invasive prenatal testing for subchromosomal abnormalities. Am J Hum Genet. 2016;98(1):34-44.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu SCY, Jiang P, Choy KW, et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One. 2013;8(4):e60968.</Citation>
        </Reference>
        <Reference>
          <Citation>Liang D, Cram DS, Tan H, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019;21(9):1998-2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Fiorentino F, Bono S, Pizzuti F, et al. The clinical utility of genome-wide non invasive prenatal screening. Prenat Diagn. 2017;37(6):593-601.</Citation>
        </Reference>
        <Reference>
          <Citation>Pertile MD, Halks-Miller M, Flowers N, et al. Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease. Sci Transl Med. 2017;9(405):eaan1240.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Opstal D, van Maarle MC, Lichtenbelt K, et al. Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study. Genet Med. 2018;20(5):480-485.</Citation>
        </Reference>
        <Reference>
          <Citation>Benn P, Grati FR. Genome-wide non-invasive prenatal screening for all cytogenetically visible imbalances. Ultrasound Obstet Gynecol. 2018;51(4):429-433.</Citation>
        </Reference>
        <Reference>
          <Citation>Izumi K, Krantz ID. Pallister-Killian syndrome. Am J Med Genet C Semin Med Genet. 2014;166C(4):406-413.</Citation>
        </Reference>
        <Reference>
          <Citation>Bartsch O, Loitzsch A, Kozlowski P, Mazauric ML, Hickmann G. Forty-two supernumerary marker chromosomes (SMCs) in 43,273 prenatal samples: chromosomal distribution, clinical findings, and UPD studies. Eur J Hum Genet. 2005;13(11):1192-1204.</Citation>
        </Reference>
        <Reference>
          <Citation>Schinzel A. Tetrasomy 12p (Pallister-Killian syndrome). J Med Genet. 1991;28(2):122-125.</Citation>
        </Reference>
        <Reference>
          <Citation>Peltomäki P, Knuutila S, Ritvanen A, Kaitila I, de la Chapelle A. Pallister-Killian syndrome: cytogenetic and molecular studies. Clin Genet. 1987;31(6):399-405.</Citation>
        </Reference>
        <Reference>
          <Citation>Schaefer GB, Jochar A, Muneer R, Sanger WG. Clinical variability of tetrasomy 12p. Clin Genet. 1997;51(2):102-108.</Citation>
        </Reference>
        <Reference>
          <Citation>Doray B, Girard-Lemaire F, Gasser B, et al. Pallister-Killian syndrome: difficulties of prenatal diagnosis. Prenat Diagn. 2002;22(6):470-477.</Citation>
        </Reference>
        <Reference>
          <Citation>Polityko AD, Goncharova E, Shamgina L, et al. Pallister-Killian syndrome: rapid decrease of isochromosome 12p frequency during amniocyte subculturing. Conclusion for strategy of prenatal cytogenetic diagnostics. J Histochem Cytochem. 2005;53(3):361-364.</Citation>
        </Reference>
        <Reference>
          <Citation>Salzano E, Raible SE, Kaur M, et al. Prenatal profile of Pallister-Killian syndrome: retrospective analysis of 114 pregnancies, literature review and approach to prenatal diagnosis. Am J Med Genet A. 2018;176(12):2575-2586.</Citation>
        </Reference>
        <Reference>
          <Citation>Karaman B, Kayserili H, Ghanbari A, et al. Pallister-Killian syndrome: clinical, cytogenetic and molecular findings in 15 cases. Mol Cytogenet. 2018;11:45.</Citation>
        </Reference>
        <Reference>
          <Citation>Thakur S, Gupta R, Tiwari B, Singh N, Saxena KK. Pallister-Killian syndrome: review of fetal phenotype. Clin Genet. 2019;95(1):79-84.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu SCY, Jiang P, Chan KCA, et al. Combined count- and size-based analysis of maternal plasma DNA for noninvasive prenatal detection of fetal subchromosomal aberrations facilitates elucidation of the fetal and/or maternal origin of the aberrations. Clin Chem. 2017;63(2):495-502.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang H, Dong Z, Zhang R, et al. Low-pass genome sequencing versus chromosomal microarray analysis: implementation in prenatal diagnosis. Genet Med. 2020;22(3):500-510.</Citation>
        </Reference>
        <Reference>
          <Citation>Frisova V, Svobodova IT, Tozzi M, Raskova D. Prenatal diagnosis of Pallister-Killian syndrome in pregnancy with normal CVS result and abnormal ultrasound findings in the second trimester. Taiwan J Obstet Gynecol. 2018;57(5):726-729.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilkens A, Liu H, Park K, et al. Novel clinical manifestations in Pallister-Killian syndrome: comprehensive evaluation of 59 affected individuals and review of previously reported cases. Am J Med Genet A. 2012;158A(12):3002-3017.</Citation>
        </Reference>
        <Reference>
          <Citation>van der Meij KRM, Sistermans EA, Macville MVE, et al. TRIDENT-2: National Implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in The Netherlands. Am J Hum Genet. 2019 Dec 5;105(6):1091-1101.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
